Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency

The bladder urothelium plays an important role of barrier function to prevent influx of urinary toxic substance and bacteria. When there is insult to the urinary bladder, the urothelium will start to regenerate on injury. However, several factors might affect the regenerative function of bladder uro...

Full description

Saved in:
Bibliographic Details
Main Authors: Qian-Sheng Ke, Jia-Fong Jhang, Teng-Yi Lin, Han-Chen Ho, Yuan-Hong Jiang, Yuan-Hsiang Hsu, Hann-Chorng Kuo
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2019-01-01
Series:Tzu Chi Medical Journal
Subjects:
Online Access:http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2019;volume=31;issue=3;spage=135;epage=143;aulast=Ke
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849724946253611008
author Qian-Sheng Ke
Jia-Fong Jhang
Teng-Yi Lin
Han-Chen Ho
Yuan-Hong Jiang
Yuan-Hsiang Hsu
Hann-Chorng Kuo
author_facet Qian-Sheng Ke
Jia-Fong Jhang
Teng-Yi Lin
Han-Chen Ho
Yuan-Hong Jiang
Yuan-Hsiang Hsu
Hann-Chorng Kuo
author_sort Qian-Sheng Ke
collection DOAJ
description The bladder urothelium plays an important role of barrier function to prevent influx of urinary toxic substance and bacteria. When there is insult to the urinary bladder, the urothelium will start to regenerate on injury. However, several factors might affect the regenerative function of bladder urothelium, including aging, chronic inflammation, and system diseases such as diabetes and chronic kidney diseases (CKDs). Impairment of bladder mucosal regenerative function might result in defective urothelial cell differentiation as well as barrier function, which might be the underlying pathophysiology of interstitial cystitis/bladder pain syndrome (IC/BPS) and recurrent bacterial cystitis. Our previous immunohistochemistry (IHC) study and electron microscopic study revealed that the loss of normal umbrella cells and defective junction proteins in IC/BPS and recurrent cystitis. Platelet-rich plasma (PRP) has been previously used in many medical aspects as regenerative medicine therapy. PRP is rich in many growth factors and cytokines which modulate the process of inflammation and regeneration in the wound healing process. Recent pilot studies have shown that intravesical PRP injections improve IC symptoms and yield a success rate of 70% at 3 months after treatment. The results highly suggest that PRP injection could improve urothelial regenerative function and reduce chronic inflammation in IC patients. This article reviews recently published researches on the urothelial dysfunction biomarkers, urothelial cell differentiation, and urinary regenerative and inflammatory proteins in patients with IC/BPS or recurrent bacterial cystitis. The pathophysiology of the insufficient urothelial regeneration and differentiation; and chronic inflammation may induce urothelial dysfunction and further affect the regenerative ability of the diseased bladder urothelium in IC/BPS and recurrent bacterial cystitis are discussed.
format Article
id doaj-art-e75e2368dca7469d9c7bfe2e628087bf
institution DOAJ
issn 1016-3190
2223-8956
language English
publishDate 2019-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Tzu Chi Medical Journal
spelling doaj-art-e75e2368dca7469d9c7bfe2e628087bf2025-08-20T03:10:36ZengWolters Kluwer Medknow PublicationsTzu Chi Medical Journal1016-31902223-89562019-01-0131313514310.4103/tcmj.tcmj_92_19Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiencyQian-Sheng KeJia-Fong JhangTeng-Yi LinHan-Chen HoYuan-Hong JiangYuan-Hsiang HsuHann-Chorng KuoThe bladder urothelium plays an important role of barrier function to prevent influx of urinary toxic substance and bacteria. When there is insult to the urinary bladder, the urothelium will start to regenerate on injury. However, several factors might affect the regenerative function of bladder urothelium, including aging, chronic inflammation, and system diseases such as diabetes and chronic kidney diseases (CKDs). Impairment of bladder mucosal regenerative function might result in defective urothelial cell differentiation as well as barrier function, which might be the underlying pathophysiology of interstitial cystitis/bladder pain syndrome (IC/BPS) and recurrent bacterial cystitis. Our previous immunohistochemistry (IHC) study and electron microscopic study revealed that the loss of normal umbrella cells and defective junction proteins in IC/BPS and recurrent cystitis. Platelet-rich plasma (PRP) has been previously used in many medical aspects as regenerative medicine therapy. PRP is rich in many growth factors and cytokines which modulate the process of inflammation and regeneration in the wound healing process. Recent pilot studies have shown that intravesical PRP injections improve IC symptoms and yield a success rate of 70% at 3 months after treatment. The results highly suggest that PRP injection could improve urothelial regenerative function and reduce chronic inflammation in IC patients. This article reviews recently published researches on the urothelial dysfunction biomarkers, urothelial cell differentiation, and urinary regenerative and inflammatory proteins in patients with IC/BPS or recurrent bacterial cystitis. The pathophysiology of the insufficient urothelial regeneration and differentiation; and chronic inflammation may induce urothelial dysfunction and further affect the regenerative ability of the diseased bladder urothelium in IC/BPS and recurrent bacterial cystitis are discussed.http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2019;volume=31;issue=3;spage=135;epage=143;aulast=KeBladder urotheliumInterstitial cystitisPlatelet-rich plasma
spellingShingle Qian-Sheng Ke
Jia-Fong Jhang
Teng-Yi Lin
Han-Chen Ho
Yuan-Hong Jiang
Yuan-Hsiang Hsu
Hann-Chorng Kuo
Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency
Tzu Chi Medical Journal
Bladder urothelium
Interstitial cystitis
Platelet-rich plasma
title Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency
title_full Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency
title_fullStr Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency
title_full_unstemmed Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency
title_short Therapeutic potential of intravesical injections of platelet-rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency
title_sort therapeutic potential of intravesical injections of platelet rich plasma in the treatment of lower urinary tract disorders due to regenerative deficiency
topic Bladder urothelium
Interstitial cystitis
Platelet-rich plasma
url http://www.tcmjmed.com/article.asp?issn=1016-3190;year=2019;volume=31;issue=3;spage=135;epage=143;aulast=Ke
work_keys_str_mv AT qianshengke therapeuticpotentialofintravesicalinjectionsofplateletrichplasmainthetreatmentoflowerurinarytractdisordersduetoregenerativedeficiency
AT jiafongjhang therapeuticpotentialofintravesicalinjectionsofplateletrichplasmainthetreatmentoflowerurinarytractdisordersduetoregenerativedeficiency
AT tengyilin therapeuticpotentialofintravesicalinjectionsofplateletrichplasmainthetreatmentoflowerurinarytractdisordersduetoregenerativedeficiency
AT hanchenho therapeuticpotentialofintravesicalinjectionsofplateletrichplasmainthetreatmentoflowerurinarytractdisordersduetoregenerativedeficiency
AT yuanhongjiang therapeuticpotentialofintravesicalinjectionsofplateletrichplasmainthetreatmentoflowerurinarytractdisordersduetoregenerativedeficiency
AT yuanhsianghsu therapeuticpotentialofintravesicalinjectionsofplateletrichplasmainthetreatmentoflowerurinarytractdisordersduetoregenerativedeficiency
AT hannchorngkuo therapeuticpotentialofintravesicalinjectionsofplateletrichplasmainthetreatmentoflowerurinarytractdisordersduetoregenerativedeficiency